- Home
- DARE vs STEC Comparison
DARE vs STEC Comparison
Compare DARE & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- STEC
- Stock Information
- Founded
- DARE 2015
- STEC 2006
- Country
- DARE United States
- STEC Hong Kong
- Employees
- DARE N/A
- STEC N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- STEC
- Sector
- DARE Health Care
- STEC
- Exchange
- DARE Nasdaq
- STEC NYSE
- Market Cap
- DARE 26.3M
- STEC 63.8M
- IPO Year
- DARE N/A
- STEC 2021
- Fundamental
- Price
- DARE $2.39
- STEC $0.74
- Analyst Decision
- DARE Strong Buy
- STEC
- Analyst Count
- DARE 3
- STEC 0
- Target Price
- DARE $12.50
- STEC N/A
- AVG Volume (30 Days)
- DARE 4.6M
- STEC 12.8K
- Earning Date
- DARE 08-11-2025
- STEC 08-05-2025
- Dividend Yield
- DARE N/A
- STEC N/A
- EPS Growth
- DARE N/A
- STEC N/A
- EPS
- DARE N/A
- STEC N/A
- Revenue
- DARE $25,909.00
- STEC $10,672,000.00
- Revenue This Year
- DARE $74,787.57
- STEC $9,392.20
- Revenue Next Year
- DARE $141.76
- STEC N/A
- P/E Ratio
- DARE N/A
- STEC N/A
- Revenue Growth
- DARE N/A
- STEC N/A
- 52 Week Low
- DARE $2.11
- STEC $0.20
- 52 Week High
- DARE $9.19
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- DARE 43.58
- STEC 38.03
- Support Level
- DARE $2.44
- STEC $0.70
- Resistance Level
- DARE $2.80
- STEC $0.80
- Average True Range (ATR)
- DARE 0.66
- STEC 0.08
- MACD
- DARE 0.01
- STEC 0.00
- Stochastic Oscillator
- DARE 5.23
- STEC 34.03
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.